Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Homology Medicines, Inc. (not Q32 Bio Inc.) on June 17, 2021. The filing details the voting results for director elections and the ratification of the independent auditor. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol FIXX.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
A total of 49,251,901 shares were present or represented by proxy, representing approximately 86.3% of outstanding common stock. All proposals were approved:
- Item 1 (Director Elections): Three Class III Directors were elected to serve until the 2024 Annual Meeting.
- Matthew R. Patterson: 36,910,361 votes FOR; 2,417,770 votes WITHHELD.
- Mary Thistle: 36,941,653 votes FOR; 2,386,478 votes WITHHELD.
- Arthur O. Tzianabos, Ph.D.: 34,090,063 votes FOR; 5,238,068 votes WITHHELD.
- Item 2 (Auditor Ratification): Deloitte & Touche LLP was ratified as the independent registered public accounting firm for the year ending December 31, 2021.
- Votes FOR: 49,153,815
- Votes AGAINST: 55,726
- Votes ABSTAINED: 42,360
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management commentary on future outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of stockholder voting results.
Key Facts for Investor Verification
- Verify the company name is Homology Medicines, Inc. (FIXX), as the input metadata incorrectly referenced Q32 Bio Inc.
- Confirm the election of the three Class III Directors and their terms extending to 2024.
- Note the high level of shareholder participation (86.3%) and the overwhelming support for the auditor ratification.
- Review the definitive proxy statement filed on April 29, 2021, for detailed biographies of the nominees and further context on the proposals.